Multi-center MRD Registry for Inflammatory Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Key facts

Study ID

NCT06966050

Run by

M.D. Anderson Cancer Center

People needed

200

Starts

2025-05-05

Expected to finish

2032-05-31

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Female or males ≥18 years of age with the ability to understand and sign a written
• Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
• Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
• Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
• Participants must be English-speaking.

Where it is running

• MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.